Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

News Feature in 2016

Filter By:

Article Type
Year
  • Detecting cancer by liquid biopsy is attracting a lot of money and hype. Can it deliver on its promise to transform oncology? Sarah Webb reports.

    • Sarah Webb
    News Feature
  • Electroceutical devices that stimulate the peripheral nervous system come to the fore. Emily Waltz reports.

    • Emily Waltz
    News Feature
  • Skeletal muscle atrophy offers a huge opportunity for an effective drug. After many failures, industry may be on the verge. Ken Garber reports.

    • Ken Garber
    News Feature
  • Spanish researchers are testing GM low-gliadin wheat for gluten-allergy sufferers. But stifling EU bureaucracy and adoption challenges may mean an uphill struggle to market. Lucas Laursen investigates.

    • Lucas Laursen
    News Feature
  • Novel drug approvals in the United States surpassed even 2014's unprecedented totals. The broad trends are familiar but, as Chris Morrison reports, 2015 had its share of pioneering achievements.

    • Chris Morrison
    News Feature
  • Electronic drugs and delivery systems are reaching the market, giving drug developers and healthcare providers a way to improve patient compliance and more. Emily Waltz reports.

    • Emily Waltz
    News Feature

Search

Quick links